Transcript Shock

Shock
Anatomy and Physiology of
Cardiovascular System





CO = SV * HR (Normal = 4.0 - 8.0 l/min)
MAP = Dist. Pressure + 1/3 Pulse Pressure
(Normal = 70 - 105 mmHg)
Preload (volume)
After load (SVR)
Contractility
Shock

It is a state of generalized cellular
hypoperfusion in which delivery of oxygen at
the cellular level is inadequate to meet
metabolic needs.
Signs and Symptoms of Shock





Decreased LOC, anxiety, disorientation.
Tachycardia, decreased SBP and pulse
pressure
Rapid shallow breathing
Cold, pale, clammy, diaphoretic, cyanotic
skin, decreased capillary refill time.
Decreased urine output
Classification of Shock



Hypovolemic shock (blood)
Distributive shock (vasogenic)
Cardiogenic (heart)
Severity of Shock



Compensated shock: patient is developing
shock but body still able to maintain
perfusion.
Decompensated shock: patient developed
shock but body no longer can compensate.
Irreversible shock: patient developed shock
but body is unable to maintain perfusion to
organs.
Hypovolemic Shock


It is the most common cause of shock in
trauma patients.
Causes:


External: bleeding (trauma), GI bleeding,
ruptured aneurysms, hemorrhagic pancreatitis.
vomiting or diarrhea, adrenal insufficiency,
diabetes insipidus, dehydration
Internal: third spacing: intestinal obstruction,
pancreatitis, cirrhosis
Hypovolemic Shock



Markers: UOP,CVP, BP, HR, Hct, CO
Treatment: ABCs, IVF (crystalloid), Blood
Transfusion.
Patients on β-blockers, or with spinal shock &
athletes may not be presented with
tachycardia.
Categories of Hemorrhagic Shock
Class I
Class II
Class III
Class IV
Blood Loss %
< 750 ml
< 15 %
750-1500 ml
(15-30 %)
1500-2000 ml
(30-40 %)
> 2000 ml
> 40 %
HR (b/min)
Normal or
minimally ↑
> 100
> 120
> 140
Ventilatory R.
(breath/min)
Normal
20 – 30
30 – 40
> 35
SBP
Normal
Normal
Decreased
Greatly
Decreased
Urine Output
(ml/hr)
Normal
20 – 30
5 – 15
Minimal
Distributive (Vasogenic) Shock

It occurs when vascular container enlarges
without a proportional increase in fluid
volume.



Septic Shock
Neurogenic Shock
Psychogenic (vasovagal) Shock
Septic Shock




Caused by cytokines release in response to
infection, sepsis: G(-/+ ) septicemia, e.g.
pneumonia, peritonitis, etc.
S & S: cool, clammy, pale, mottled skin, BP
drop, altered LOC, slowed capillary refill.
Markers: Temp, WBC count, …
Rx: ABCs, IVF, Drainage (ie abscess).
Neurogenic Shock



It occurs when injury interrupts the spinal
cord sympathetic nervous system pathway.
S & S: warm, dry, pink skin, bradycardia, BP
drop, lucid LOC, normal capillary refill.
Rx: IVF, vasoactive medications if refractory
Psychogenic Shock


It is mediated through parasympathetic
nervous system. (stimulation of vagal nerve)
It is temporary state lasts for few minutes.
Cardiogenic Shock


Failure of the heart’s pumping activity.
Intrinsic Causes:




Heart muscle damage
Dysrhythmia
Valvular disruption
Extrinsic Causes:


Cardiac tamponade
Tension pneumothorax
Cardiogenic Shock



S & S: cool, clammy, pale, cyanotic skin, BP
drop, altered LOC, slowed capillary refill.
Markers: CXR, CVP, CO.
Rx: diuretics & vasodilators +/- pressures,
decrease after load, intraaortic balloon pump
Complications of Shock





Acute Renal Failure
Acute Respiratory Distress Syndrome
Hematologic Failure
Hepatic Failure
Multiple Organ Failure
Volume Resuscitation


Enteral Route
Vascular Access


Intravenous route
Intraosseous route
Intravenous Solutions

Crystalloids Solutions





Hypotonic solutions
Isotonic solutions
Hypertonic solutions
Colloids Solutions
Blood Substitutes
Colloids
 High molecular weight substances so do not
cross capillary membranes.
 Used as volume or plasma expanders
 They include:
 Albumin
 Hetastarch
 Dextran
Blood



It is given as packed RBCs, which should be crossmatched, but in an urgent situation, 1 to 2 units of
type O Rh-negative blood are an acceptable
alternative.
When > 1 to 2 units are transfused (eg, in major
trauma), blood is warmed to 37° C.
Patients receiving > 8 to 10 units may require
replacement of clotting factors with infusion of fresh
frozen plasma or cryoprecipitate and platelet
transfusion.